Manager, MSAT Process Engineer

We are looking for an experienced and motivated Manager, MSAT Process Engineer to join our team at Glaxo Smith Kline. The ideal candidate will have a proven track record of success in engineering and manufacturing process support and possess a strong background in managing and leading teams. If you are a dedicated professional who is comfortable working in a fast-paced environment and have a passion for delivering innovative solutions, this could be the opportunity for you.The Manager, MSAT Process Engineer will be responsible for providing process engineering and manufacturing support to MSAT operations and projects. The successful candidate will collaborate with process and manufacturing teams to design, develop, and implement process improvements. They will also provide technical leadership and direction to the MSAT Process Engineering team.To be successful in this role, you will need a degree in engineering, preferably in chemical engineering, or a related field and a minimum of 5-7 years of relevant experience in a process engineering role. You should also have experience in industrial process engineering and knowledge of current industry standards related to process safety and quality assurance. Excellent problem solving, communication and interpersonal skills are essential for this role.If this sounds like the perfect opportunity for you, we look forward to receiving your application.

According to JobzMall, the average salary range for a Manager, MSAT Process Engineer in Cambridge, UK is between £45,000 and £60,000 per year. This salary range includes a range of benefits such as bonuses, pension contributions, healthcare, and other allowances. The salary range may vary depending on the employer, experience, and qualifications of the job applicant.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.